A data-driven platform for population health
From population genomics programs to high-throughput COVID-19 testing, Color provides the technology and infrastructure for large-scale health initiatives.Color’s COVID-19 Response
Designed for people. Built for populations.
Population Genomics Platform
We provide the technology and services to power successful population genomics programs. Our platform can be deployed as a complete, end-to-end solution or used modularly to support existing capabilities.
Learn how you can send Color’s saliva test kits to your patients’ homes or order testing in your clinic. Get actionable results and access to our board-certified genetic counselors.
Revolutionizing healthcare delivery and research with leaders in population genomics
From the National Institutes of Health’s All of Us Research Program, to premier health systems, and partnerships with leading employers around the world.
For Health Systems
Bring innovation to patient care delivery.
Organic engagement with clinical value
Attract new patients in a competitive market with easy access to clinical-grade genetic information.
Unique insights for your population
Manage patient health at the individual and population levels with ongoing data collection.
Personalized routing to care pathways
Drive desired behavior with digital onboarding and routing to the right care pathways for each patient.
Increased capacity at lower cost
Transform your cost structures with digital tools to make virtual and in-person clinical services more efficient.Learn More
Spotlight on Research
Return genetic results to your population at scale.
NIH / All of Us
All of Us is sequencing one million people to accelerate health research and enable individualized prevention, treatment, and care.
UCSF / WISDOM
WISDOM is providing genetic testing for 100,000 women to make breast cancer screening more effective.
SU2C / MAGENTA
MAGENTA provides genetic testing and tele-counseling to women at high risk of cancer.
UW / GENtleMEN
GENtleMEN provides genetic testing and counseling to men with metastatic prostate cancer.
Transform your employees’ engagement in their health decisions.
Personal context for healthcare decisions
Activate employees with clinical-grade genetics, personal and family health history, and other insights.
Increased participation and engagement
Get employees to be more proactive about their health with personalized routing to relevant screening guidelines and benefits programs.
Better control over costly health events
Mitigate costly health events by helping high-risk populations earlier.
Insights to help inform benefits planning
Receive custom reports with ongoing aggregated insights into your population’s health.Learn More
The Latest from Color
Color receives FDA authorization for COVID-19 test tech that speeds up results
Color has received an EUA from the FDA for a COVID-19 testing method that is as accurate as current tests, is about 50% faster and has different supply requirements.
To Get Back to Work, Companies Seek Coronavirus Tests for Workers
“The core tool we have to work with right now is direct covid testing,” said Othman Laraki, CEO of genetic-testing company Color, which is currently managing a testing site for San Francisco first responders as well as other essential city employees.
Color announces $75 million funding round
Fortune Exclusive details $75 million funding round led by T. Rowe Funds and Viking Global Investors.
“NorthShore has long been committed to integrating genomics into the frontline of care, our primary care practices. Our partnership with Color takes that to the next level.”
“We are proud to deliver the most advanced cancer care and provide access to critical genetic information for all of our patients to help them create a personalized care plan. This exciting new partnership demonstrates our shared goal of opening up access to potentially life-saving genetic information and helping people lead healthier lives.”
“I’m a big believer in people taking responsibility for their own health and well-being. And this just gives them more tools to do that.”